Church of PeptidesSearch
Portrait of Linaclotide
New Disciples · approved 2012

Linaclotide

The River Opener

United States

Linaclotide is an oral peptide that activates guanylate cyclase-C on the intestinal surface, increasing fluid secretion and helping stool move. It treats defined constipation disorders; the eligible age group depends on the diagnosis and current product label.

Evidence ladder: Approved human useApproved human use · product-specific labelsEducational record
ClassificationNew Disciples
Evidence summaryApproved human use · product-specific labels
OriginUnited States
Scientific record

What the evidence says

Established role or proposed benefit

  • Increases intestinal fluid secretion and transit.
  • Can improve constipation and abdominal pain in labeled disorders.

Side effects, risks, and limits

  • Diarrhea can be severe.
  • Important pediatric contraindications and warnings apply.
Doctide’s verdict

The River Opener is a locally acting intestinal medicine with defined clinical uses. Opening the water gates can help constipation, but excessive flow is an adverse effect, and age and diagnosis belong in the same sentence as benefit.

Documented history

Where the real story begins

LINZESS first received US approval in 2012. Its prescribing information now distinguishes adult constipation indications from specific pediatric indications, reflecting separate clinical development rather than one approval for every age and every form of constipation. Historical source.

United States · approved 2012
Book of the Canon · comic scripture

The laboratory legend

Linaclotide found the intestinal road completely stalled and opened the water gates. Doctide learned that opening them too far creates a different emergency.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. This authoritative medication reference describes particular medicinal formulations and uses; it is not evidence for every preparation or off-label claim.

  1. MedlinePlus: medication-specific uses and precautions
  2. FDA Drugs@FDA database
  3. LINZESS prescribing information

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.